Researchers throughout Arizona are making great strides in learning more about the impacts of COVID-19, vaccine effectiveness, and potential treatments. Northern Arizona University researchers believe Stenoparib, a drug being studied to treat ovarian cancer, can be combined with Remdesivir to treat those infected with COVID-19. At the University of Arizona, researchers plan to test vaccine effectiveness against COVID-19 variants for people with compromised immune systems. And Banner Sun Health in Sun City has released a preliminary report about its findings from a federally funded study mapping the invasion of COVID-19 in the brain.
UA researchers study immunity against new coronavirus variants / Arizona Republic
Researchers ramp up COVID-19 variant tracking efforts in Arizona / KOLD
What is a COVID-19 variant and what do they mean for the community? / ABC 15
NAU researchers find drug combination that would help treat those with COVID-19 / 12 News
Banner Sun Health looks at what happens when COVID-19 invades the brain / KJZZ
Data shows far more white seniors in Arizona are getting COVID-19 vaccines than seniors of color. The inequity could get worse / Arizona Republic
East Valley to get state-run COVID-19 vaccine site next week / KTAR
Maricopa County closing 2 COVID-19 vaccine pods, changing distribution / KTAR
COVID-19 vaccine FAQ, Arizona National Guard, mobile vaccinations / Arizona Public Media
Daily COVID-19 cases in Arizona drop below 1,000 / AZ Big Media
Cancer screenings plunge during pandemic as risk shifts / AZ Big Media
Northern Arizona University president finalist Cruz seeks new university vision / Arizona Daily Sun
As Northern Arizona University’s 17th president, electrical engineer and educator José Luis Cruz wants to bring the school the same worldwide recognition as its sister universities through a vision that can be backed by the entire community. Read more: ‘Hit the ground learning’: Dr. José Luis Cruz is set to become 17th president of Northern Arizona University
7 Arizona bioscience startups receive $30K in entrepreneurship program / KTAR
Seven Arizona-based bioscience startups selected for the 2021 Flinn Foundation Bioscience Entrepreneurship Program will each receive $30,000 in funding support through a nonprofit partner, a personalized learning plan to help advance the company, and connections with the state’s bioscience leaders in business, research, and policy. Read more: 7 bioscience startups earn $30K through Flinn entrepreneurship program
Upcoming Events
Feb. 25-Feb. 28: Arizona SciTech Festival
March 2: Viral overload: Do viruses impact cancer?